Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Arch Therapeutics, Inc. (ARTHQ) had Debt to Equity Ratio of -0.75 for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
$0.08M |
|
$-6.98M |
|
$0.08M |
|
$-0.00M |
|
$5.12M |
|
$-5.04M |
|
$-1.94M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-6.98M |
|
$-5.04M |
|
$-5.04M |
|
3.07M |
|
3.07M |
|
$-2.27 |
|
$-2.27 |
|
| Balance Sheet Financials | |
$1.95M |
|
$0.00M |
|
$0.01M |
|
$1.96M |
|
$9.47M |
|
-- |
|
-- |
|
$9.47M |
|
$-7.51M |
|
$-7.51M |
|
$-7.51M |
|
4.69M |
|
| Cash Flow Statement Financials | |
$-3.37M |
|
$-0.00M |
|
$2.85M |
|
$0.75M |
|
$0.22M |
|
$-0.52M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.21 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-0.75 |
-3.22% |
|
-6661.67% |
|
-6661.67% |
|
-6659.07% |
|
-9221.43% |
|
-9221.43% |
|
$-3.38M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.06 |
|
-- |
|
-- |
|
93.01% |
|
93.01% |
|
-356.60% |
|
93.01% |
|
$-1.60 |
|
$-1.10 |
|
$-1.10 |
|